How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Living Donor Protection Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · third_quarter · Q3
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Source: Senate LDA
Initiatives to increase and facilitate organ donation and transplantation. Comments to HHS regarding Organ Procurement Organization Conditions for Coverage. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to address access and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Early detection and management of Chronic Kidney Disease, including recommendation to provide CKD screening in Federally Qualified Health Centers. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Prescription drug pricing and access. Affordable Care Act access and utilization.
Living Donor Protection Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Treat and Reduce Obesity Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Treat and Reduce Obesity Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Jack Reynolds Memory Medigap Expansion Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Jack Reynolds Memory Medigap Expansion Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers).
Jack Reynolds Memory Medigap Expansion Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Healthcare Workforce Resilience Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Medical Nutrition Therapy Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Medical Nutrition Therapy Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Improving Access to Home Dialysis Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Healthcare Workforce Resilience Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
CONNECT for Health Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Medical Nutrition Therapy Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Medical Nutrition Therapy Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Expanding Access to Diabetes Self-Management Training Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Expanding Access to Diabetes Self-Management Training Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Living Donor Protection Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Living Donor Protection Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Living Donor Protection Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. Comments to HHS regarding Organ Procurement Organization Conditions for Coverage. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to address access and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Early detection and management of Chronic Kidney Disease, including recommendation to provide CKD screening in Federally Qualified Health Centers. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Prescription drug pricing and access. Affordable Care Act access and utilization.
Treat and Reduce Obesity Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Treat and Reduce Obesity Act of 2021
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis (including patients with acute kidney injury), access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Video conference discussion with HRSA Division of Transplantation to discuss various issues surrounding organ donation Comments on proposed expansion of reimbursement of travel and subsistence expenses associated with living organ donation Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Comments on Organ Procurement Organization Conditions of Coverage for Outcomes Measures Comments on proposed revisions to living organ donor financial assistance Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353 Comments on the Advanced Notice for Medicare Advantage Capitation and Part C and Part D payments Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Medicare Hospital Inpatient Prospective Payment System and Medicare and Medicaid Interoperability Programs Requirements. Comments on Medicare ESRD Prospective Payment System and Quality Incentive Program. Comments on Medicare Physician Fee Service and Quality Payment Program. Increased use of Kidney Discards for transplantation. Access of medications under Medicare Part D Protected Classes.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis and other home health benefits Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353) Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Proposed Rule for changes to Medicare Advantage (including enrollment of ESRD patients), Medicare prescription drug program, and Medicare Cost Plan Program Comments on Origin and Destination Requirements under the Ambulance Fee Schedule Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Support for H.R. 6971, Medical Nutrition Therapy Act
Medical Nutrition Therapy Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis and other home health benefits Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353) Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Proposed Rule for changes to Medicare Advantage (including enrollment of ESRD patients), Medicare prescription drug program, and Medicare Cost Plan Program Comments on Origin and Destination Requirements under the Ambulance Fee Schedule Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Support for H.R. 6971, Medical Nutrition Therapy Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353 Comments on the Advanced Notice for Medicare Advantage Capitation and Part C and Part D payments Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis and other home health benefits Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353) Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Proposed Rule for changes to Medicare Advantage (including enrollment of ESRD patients), Medicare prescription drug program, and Medicare Cost Plan Program Comments on Origin and Destination Requirements under the Ambulance Fee Schedule Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Support for H.R. 6971, Medical Nutrition Therapy Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Medicare Hospital Inpatient Prospective Payment System and Medicare and Medicaid Interoperability Programs Requirements. Comments on Medicare ESRD Prospective Payment System and Quality Incentive Program. Comments on Medicare Physician Fee Service and Quality Payment Program. Increased use of Kidney Discards for transplantation. Access of medications under Medicare Part D Protected Classes.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Comments on Organ Procurement Organization Conditions of Coverage for Outcomes Measures Comments on proposed revisions to living organ donor financial assistance Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis (including patients with acute kidney injury), access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Video conference discussion with HRSA Division of Transplantation to discuss various issues surrounding organ donation Comments on proposed expansion of reimbursement of travel and subsistence expenses associated with living organ donation Prescription Drug Pricing and Access Management of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Comments on Donation Service Areas for organ allocation Comments on Public Health Service Guidelines on organ allocation and utilization Prescription Drug Pricing and Access Reauthorization of the Patient-Centered Outcomes Research Institute Management of the Affordable Care Act Repeal and Replacement of the Affordable Care Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534) Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Comments on Donation Service Areas for organ allocation Comments on Public Health Service Guidelines on organ allocation and utilization Prescription Drug Pricing and Access Reauthorization of the Patient-Centered Outcomes Research Institute Management of the Affordable Care Act Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Proposed Alternative Payment Model for Chronic Kidney Disease care Comments on ESRD Prospective Payment System and Quality Incentive Program proposed rule Comments on payment policies under the Physician Fee Schedule; Medicare Shared Savings Program; and Quality Payment Program Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867). Proposed Alternative Payment Model for Chronic Kidney Disease care. Comments on Efficiency and Transparency Transplant Conditions of Participation, including organ discards. Comments on Proposed Rule Making for Part B drugs. Medicare Part D Protected Classes status. Increased utilization of home kidney dialysis. Medicare coverage of immunosuppressive drugs for kidney transplant recipients.
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · second_quarter · Q2
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · first_quarter · Q1
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers).
Initiatives to increase and facilitate organ donation and transplantation. Comments to HHS regarding Organ Procurement Organization Conditions for Coverage. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to address access and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Early detection and management of Chronic Kidney Disease, including recommendation to provide CKD screening in Federally Qualified Health Centers. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Prescription drug pricing and access. Affordable Care Act access and utilization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · fourth_quarter · Q4
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · third_quarter · Q3
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Medicare Hospital Inpatient Prospective Payment System and Medicare and Medicaid Interoperability Programs Requirements. Comments on Medicare ESRD Prospective Payment System and Quality Incentive Program. Comments on Medicare Physician Fee Service and Quality Payment Program. Increased use of Kidney Discards for transplantation. Access of medications under Medicare Part D Protected Classes.
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · second_quarter · Q2
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis and other home health benefits Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353) Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Proposed Rule for changes to Medicare Advantage (including enrollment of ESRD patients), Medicare prescription drug program, and Medicare Cost Plan Program Comments on Origin and Destination Requirements under the Ambulance Fee Schedule Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Support for H.R. 6971, Medical Nutrition Therapy Act
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis (including patients with acute kidney injury), access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Video conference discussion with HRSA Division of Transplantation to discuss various issues surrounding organ donation Comments on proposed expansion of reimbursement of travel and subsistence expenses associated with living organ donation Prescription Drug Pricing and Access Management of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · first_quarter · Q1
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Comments on Organ Procurement Organization Conditions of Coverage for Outcomes Measures Comments on proposed revisions to living organ donor financial assistance Prescription Drug Pricing and Access Management of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353 Comments on the Advanced Notice for Medicare Advantage Capitation and Part C and Part D payments Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · fourth_quarter · Q4
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534) Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Comments on Donation Service Areas for organ allocation Comments on Public Health Service Guidelines on organ allocation and utilization Prescription Drug Pricing and Access Reauthorization of the Patient-Centered Outcomes Research Institute Management of the Affordable Care Act Repeal and Replacement of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · third_quarter · Q3
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · second_quarter · Q2
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · first_quarter · Q1
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Medicare Advantage Step Therapy Modification of ICD-10-CM Codes
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · fourth_quarter · Q4
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867). Proposed Alternative Payment Model for Chronic Kidney Disease care. Comments on Efficiency and Transparency Transplant Conditions of Participation, including organ discards. Comments on Proposed Rule Making for Part B drugs. Medicare Part D Protected Classes status. Increased utilization of home kidney dialysis. Medicare coverage of immunosuppressive drugs for kidney transplant recipients.
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · third_quarter · Q3
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Proposed Alternative Payment Model for Chronic Kidney Disease care Comments on ESRD Prospective Payment System and Quality Incentive Program proposed rule Comments on payment policies under the Physician Fee Schedule; Medicare Shared Savings Program; and Quality Payment Program Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · second_quarter · Q2
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE